Description |
Diosgenin, a steroidal saponin, can inhibit STAT3 signaling pathway.
|
Target |
STAT3
|
In Vitro |
In MC65 cells, a cellular AD model, diosgenin exhibited weak protective abilities at 1 μM, may represent a good candidate as a steroidal moiety in our bivalent compounds against AD pathology[1]. Diosgenin inhibits the constitutive activation of STAT3 in C3A cells in a dose-dependent manner, with maximum inhibition occurring at around 100 μM[2].
|
In Vivo |
Diosgenin treatment significantly reduces fasted and refed blood glucose level in HF dietfed mice. Diosgenin treatment significantly reduces blood glucose level in IPGTT test, compared with that of HF diet-fed mice[3].
|
Density | 1.1±0.1 g/cm3 |
Boiling Point | 527.1±50.0 °C at 760 mmHg |
Flash Point | 272.6±30.1 °C |
Exact Mass | 414.313385 |
PSA | 38.69000 |
LogP | 5.84 |
Vapour Pressure | 0.0±3.1 mmHg at 25°C |
Storage condition | Refrigerator |